157 related articles for article (PubMed ID: 6580050)
1. Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations.
Flynn PJ; Miller WJ; Weisdorf DJ; Arthur DC; Brunning R; Branda RF
Blood; 1983 Dec; 62(6):1211-7. PubMed ID: 6580050
[TBL] [Abstract][Full Text] [Related]
2. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Huang ME; Ye YC; Chen SR; Chai JR; Lu JX; Zhoa L; Gu LJ; Wang ZY
Blood; 1988 Aug; 72(2):567-72. PubMed ID: 3165295
[TBL] [Abstract][Full Text] [Related]
3. Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia.
Nilsson B
Br J Haematol; 1984 Jul; 57(3):365-71. PubMed ID: 6589010
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia.
Daenen S; Vellenga E; van Dobbenburgh OA; Halie MR
Blood; 1986 Feb; 67(2):559-61. PubMed ID: 3455829
[TBL] [Abstract][Full Text] [Related]
5. Probing the pathobiology of response to all-trans retinoic acid in acute promyelocytic leukemia: premature chromosome condensation/fluorescence in situ hybridization analysis.
Vyas RC; Frankel SR; Agbor P; Miller WH; Warrell RP; Hittelman WN
Blood; 1996 Jan; 87(1):218-26. PubMed ID: 8547645
[TBL] [Abstract][Full Text] [Related]
6. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid.
Breitman TR; Collins SJ; Keene BR
Blood; 1981 Jun; 57(6):1000-4. PubMed ID: 6939451
[TBL] [Abstract][Full Text] [Related]
7. Use of trans-retinoic acid in the treatment of acute promyelocytic leukemia.
Dulaney AM; Murgatroyd RJ
Ann Pharmacother; 1993 Feb; 27(2):211-4. PubMed ID: 8439701
[TBL] [Abstract][Full Text] [Related]
8. The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia.
Fontana JA; Rogers JS; Durham JP
Cancer; 1986 Jan; 57(2):209-17. PubMed ID: 3455835
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy between in-vitro and in-vivo inductions of differentiation by retinoids of human acute promyelocytic leukemia cells in relapse.
Sampi K; Honma Y; Hozumi M; Sakurai M
Leuk Res; 1985; 9(12):1475-8. PubMed ID: 3866121
[TBL] [Abstract][Full Text] [Related]
10. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.
Vahdat L; Maslak P; Miller WH; Eardley A; Heller G; Scheinberg DA; Warrell RP
Blood; 1994 Dec; 84(11):3843-9. PubMed ID: 7949141
[TBL] [Abstract][Full Text] [Related]
11. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients.
Chen ZX; Xue YQ; Zhang R; Tao RF; Xia XM; Li C; Wang W; Zu WY; Yao XZ; Ling BJ
Blood; 1991 Sep; 78(6):1413-9. PubMed ID: 1884013
[TBL] [Abstract][Full Text] [Related]
12. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
[TBL] [Abstract][Full Text] [Related]
13. Treatment of refractory undifferentiated acute myelogenous leukemia with all-trans-retinoic acid.
Griggs JJ; Henley SE; Rowe JM
Am J Hematol; 1994 Feb; 45(2):177-80. PubMed ID: 8141124
[TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
[TBL] [Abstract][Full Text] [Related]
15. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
16. Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia.
Soignet SL; Benedetti F; Fleischauer A; Parker BA; Truglia JA; Ra Crisp M; Warrell RP
Leukemia; 1998 Oct; 12(10):1518-21. PubMed ID: 9766493
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil secondary-granule deficiency as a hallmark of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
Miyauchi J; Ohyashiki K; Inatomi Y; Toyama K
Blood; 1997 Jul; 90(2):803-13. PubMed ID: 9226181
[TBL] [Abstract][Full Text] [Related]
18. Terminal transferase positive acute promyelocytic leukemia: in vitro differentiation of a T-lymphocytic/promyelocytic hybrid phenotype.
Paietta E; Dutcher JP; Wiernik PH
Blood; 1985 Jan; 65(1):107-14. PubMed ID: 3871159
[TBL] [Abstract][Full Text] [Related]
19. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.
Chen SJ; Zelent A; Tong JH; Yu HQ; Wang ZY; Derré J; Berger R; Waxman S; Chen Z
J Clin Invest; 1993 May; 91(5):2260-7. PubMed ID: 8387545
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.
Castaigne S; Chomienne C; Daniel MT; Ballerini P; Berger R; Fenaux P; Degos L
Blood; 1990 Nov; 76(9):1704-9. PubMed ID: 2224119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
